An Algerian official delegation learns about the experience of the Jordanian Food and Drug Administration in monitoring and registering medicines
Amman2 min read
Share
An official delegation from the National Agency for Pharmaceutical Materials affiliated with the Ministry of Pharmaceutical Industry in the People's Democratic Republic of Algeria, during a visit to the Jordan Food and Drug Administration, learned about the institution's pioneering experience in developing an advanced system for registering chemical and biological medicines, pharmaceutical vigilance, and the regulatory procedures adopted in this field.
During her meeting with the delegation, the Director General of the institution, Professor Dr. Rana Abeidat, confirmed that the institution, as a national reference body specialized in regulating food and drugs, has built advanced expertise and experiences over its journey that keep pace with the latest developments in specialized regulatory and organizational fields, which enhanced its contribution to the exchange of expertise in developing drug regulatory systems with a number of peer regulatory bodies.
She added that the institution has developed an institutional model based on knowledge and experience, which has established its position as a reliable technical and regulatory reference, aligning the requirements for regulating and monitoring the quality of medicines with global standards, and enhancing its presence in international regulatory systems, including membership in the Pharmaceutical Inspection Co-operation Scheme (PIC/S) and reaching the final stages of obtaining the World Health Organization's accreditation.
The visit, which lasts two days, includes a training program presented by specialized experts in the Directorate of Medicines, to brief the delegation, which includes a number of specialized technicians, on the mechanisms and procedures followed in the field of registering chemical and biological medicines. The program included a presentation by the Director of the Directorate of Medicines, Dr. Rana Malkawi, which covered the system of work in various sections of the Directorate of Medicines, the adopted regulatory and technical procedures, the related work stages, and the electronic transformation and continuous development projects, in addition to a presentation on the registration of chemical medicines in the institution, and the acceleration projects presented by the Head of the Chemical Medicines Section, Dr. Shatha Al-Quraan.
